Aligos Therapeutics, Inc. (ALGS) NASDAQ
5.25
-0.1(-1.87%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.25
-0.1(-1.87%)
Currency In USD
| Market Cap | 92.13M |
| Enterprise Value | 79.07M |
| P/E Ratio | -0.6 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 6.91 |
| Price/Book Ratio | 1.72 |
| Enterprise/Revenue | 1.42 |
| Enterprise/EBITDA | -0.07 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -19.2 |
| Operating Margin | -20.33 |
| Return On Assets | -1.4 |
| Return On Equity | -1.39 |
| Revenue | 2.19M |
| Revenue/Share | 0.45 |
| Gross Profit | 1.26M |
| EBITDA | -87.06M |
| Net Income | -24.19M |
| Diluted EPS | -2.45 |
| Total Cash | 55.08M |
| Total Cash/Share | 5.29 |
| Total Debt | 4.35M |
| Total Debt/Equity | 0.14 |
| Current Ratio | 2.56 |
| Book Value Per Share | 3.06 |
| 52-Week Change | 0 |
| 52-Week High | 13.69 |
| 52-Week Low | 5.01 |
| Moving Average 50 Days | 6.64 |
| Moving Average 200 Days | 8.37 |
| Average Volume | 201,030 |
| Shares Outstanding | 6.19M |
| % Held by Institutions | 28.07 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 19, 2024 |